Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Disease Information
Management of Gaucher disease
Medical Information Services
Pharmacovigilance & Safety Information
IgG AB testing service
Gaucher Registry
Practical Information
Request Materials
Fabry
MPS I
Pompe

 



 

IgG Antibody Testing Service

As with other therapeutic proteins, IgG antibody formation towards recombinant glucocerebrosidase may occur. Patients who are positive for IgG antibodies have a higher risk of developing a hypersensitivity reaction. In general, the symptoms are manageable by administering pre-treatment with antihistamines and/or corticosteroids and by reducing the infusion rate.

Genzyme encourages treating physicians to collect serum samples for antibody testing prior to a patient's first infusion and then every six months after start of enzyme replacement therapy for two years. The antibody testing service is free of charge. Please contact your local Genzyme representative or send us an email for more information, or contact Genzyme Belgium at +32 2 714 17 11.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease